Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101787032A reveals a cost-effective clopidogrel synthesis using D-camphorsulfonic acid resolution, offering high purity and scalable manufacturing for global supply chains.
Patent CN102675216B details a novel purification process for 4,6-dichloropyrimidine, offering higher purity and yield for pharmaceutical intermediates manufacturing.
Patent CN101870636A reveals a cost-effective 3-step synthesis of 2-bromo-6-fluoronaphthalene from Tobias acid, offering significant supply chain advantages.
Novel catalytic process for Vortioxetine intermediate ensures high purity and cost efficiency. Reliable supply chain solution for global pharmaceutical manufacturing partners.
Patent CN105646319B reveals a column-free synthesis route for Brivaracetam, enabling cost reduction in API manufacturing and high-purity output suitable for commercial scale-up.
Patent CN106495991A details a CoMo catalytic process for high-purity biphenyl and OPP production, offering significant supply chain and cost advantages for global buyers.
Advanced synthesis of stable isotope labeled tauryl amine hydrochloride via CN114539106A. Delivers >98% isotopic abundance and >99% purity for pharmacokinetic research.
Patent CN101225058B details a high-purity synthesis route. Offers significant cost reduction and supply chain reliability for global polymer and pharmaceutical manufacturers.
Discover the novel synthesis of Ketorolac Tromethamine Intermediate VI via patent CN113087626A. Achieve higher purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN107417615A enables high-purity quinolinone manufacturing via visible light catalysis. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Novel ruthenium complex synthesis patent CN105440085A offers high purity and selectivity for antitumor drug manufacturing supply chain efficiency.
Patent CN107417615A enables visible light promoted synthesis of chiral quinolinone derivatives. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN118026850B reveals continuous flow nitration reducing cold utility consumption and enhancing safety for dye intermediates manufacturing.
Patent CN115010686A details a novel resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN113149937B enables high-purity 2,5-bis(aminomethyl)furan via one-pot catalysis. Offers renewable sourcing and simplified supply chain for global buyers.
Novel patent CN114031659A details a scalable route for Levonorgestrel Impurity O, offering cost-effective production and high purity for global pharmaceutical supply chains.
Patent CN110041361B reveals a visible-light driven tandem reaction for high-purity cyclopropane intermediates, offering significant cost reduction and scalable manufacturing advantages.
Stable chiral intermediate synthesis via CN109851542A. Enhanced storage stability and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Novel one-step oxidation method reduces costs and pollution for high-purity pharmaceutical intermediates manufacturing ensuring reliable supply chain continuity.
Patent CN1159320C reveals a novel onium salt route for cefepime. Achieve cost reduction in pharmaceutical intermediates manufacturing with high-purity scalable methods.